171 related articles for article (PubMed ID: 7840513)
21. The risk of premalignant and malignant pathology in endometrial polyps.
Bakour SH; Khan KS; Gupta JK
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):317-20. PubMed ID: 10746849
[TBL] [Abstract][Full Text] [Related]
22. Operative treatment of endometrial hyperplasia in kidney graft recipients: report of seven cases.
Bobrowska K; Pietrzak B; Jabiry-Zieniewicz Z; Cyganek A; Kaminski P; Wielgos M; Durlik M
Transplant Proc; 2007 Nov; 39(9):2756-8. PubMed ID: 18021979
[TBL] [Abstract][Full Text] [Related]
23. Histopathologic consistency between endometrial hyperplasia diagnosis from endometrial curettage and pathologic diagnoses from hysterectomy specimens.
Jesadapatrakul S; Tangjitgamol S; Manusirivitaya S
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S16-21. PubMed ID: 17722313
[TBL] [Abstract][Full Text] [Related]
24. Endometrial brush biopsy. An accurate outpatient method of detecting endometrial malignancy.
Wu HH; Casto BD; Elsheikh TM
J Reprod Med; 2003 Jan; 48(1):41-5. PubMed ID: 12611094
[TBL] [Abstract][Full Text] [Related]
25. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Wheeler DT; Bristow RE; Kurman RJ
Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
[TBL] [Abstract][Full Text] [Related]
26. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
[TBL] [Abstract][Full Text] [Related]
27. Endometrial hyperplasia treated by progestins.
Eichner E; Abellera M
Obstet Gynecol; 1971 Nov; 38(5):739-42. PubMed ID: 5114224
[TBL] [Abstract][Full Text] [Related]
28. The diagnosis of endometrial hyperplasia on curettage: how reliable is it?
Obeidat B; Mohtaseb A; Matalka I
Arch Gynecol Obstet; 2009 Apr; 279(4):489-92. PubMed ID: 18679697
[TBL] [Abstract][Full Text] [Related]
29. The value of curettage in diagnosis of endometrial hyperplasia.
Xie X; Lu WG; Ye DF; Chen HZ; Fu YF
Gynecol Oncol; 2002 Jan; 84(1):135-9. PubMed ID: 11748989
[TBL] [Abstract][Full Text] [Related]
30. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
[TBL] [Abstract][Full Text] [Related]
31. [Modern tendencies in treatment of atypical glandular hyperplasia--our and foreign experience].
Ivanov S; Kovachev E; Tsonev A; Abbud A
Akush Ginekol (Sofiia); 2010; 49(2):47-9. PubMed ID: 20734678
[TBL] [Abstract][Full Text] [Related]
32. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
Corrado G; Baiocco E; Carosi M; Vizza E
Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
[TBL] [Abstract][Full Text] [Related]
33. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia.
Janicek MF; Rosenshein NB
Gynecol Oncol; 1994 Mar; 52(3):373-8. PubMed ID: 8157194
[TBL] [Abstract][Full Text] [Related]
34. [Atypical hyperplasia and complex hyperplasia of endometrium in women of reproductive age].
Guo LN
Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):725-7, 760. PubMed ID: 8137643
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometrical DNA measurements in endometrial hyperplasias. A prospective follow-up study after abrasio only or additional high-dose gestagen treatment.
Lindahl B; Alm P
Anticancer Res; 1991; 11(1):391-5. PubMed ID: 1826822
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
37. Endometrial abnormalities in infertile women.
Kurabayashi T; Kase H; Suzuki M; Sugaya S; Fujita K; Tanaka K
J Reprod Med; 2003 Jun; 48(6):455-9. PubMed ID: 12856518
[TBL] [Abstract][Full Text] [Related]
38. Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia.
Eddib A; Allaf B; Lee J; Yeh J
Gynecol Obstet Invest; 2012; 73(1):38-42. PubMed ID: 22056948
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
40. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]